The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

(AP Photo/Jose Luis Magana) WASHINGTON (AP) — Government advisers are meeting Thursday to decide if COVID-19 vaccines need ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.